Last updated 2 years ago

Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis

52 patients around the world

Available in Mexico, United States

Kartos Therapeutics, Inc.

4Research sites

52Patients around the world

This study is for people with

Myeloproliferative syndromes

Myelofibrosis

Polycythemia vera

Essential thrombocythemia

Requirements for the patient

From 18 Years

All Gender

Medical requirements

Sites

Sociedad de Metabolismo y Corazón S.C

Recruiting

Alacio Pérez 661, Ricardo Flores Magón, Veracruz

Centro de Investigación Clínica de Oaxaca - Oaxaca

Recruiting

Carretera a San Luis Beltrán No.112. Col. Jardín, Oaxaca

Centro de Investigación Médica Aguascalientes - CIMA

Recruiting

Av Independencia 2130, Trojes de Alonso, Aguascalienteshttp://www.redosmo.com/cima/

Unidad de Investigación CIMA SC

Recruiting

PASCUAL OROZCO 2125, COLONIA MAGISTERIAL, Chihuahua, Chihuahua, Código Postal 31200

SponsorKartos Therapeutics, Inc.

Study typeInterventional

Conditions

MyelofibrosisPolycythemia veraEssential thrombocythemia

Requirements

From 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT04878003